180 related articles for article (PubMed ID: 35979216)
21. Traditional Chinese medicine compound ShengJinRunZaoYangXue granules for treatment of primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled clinical trial.
Hu W; Qian X; Guo F; Zhang M; Lyu C; Tao J; Gao Z; Zhou Z
Chin Med J (Engl); 2014; 127(15):2721-6. PubMed ID: 25146603
[TBL] [Abstract][Full Text] [Related]
22. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).
Ye Q; Wang H; Xia X; Zhou C; Liu Z; Xia ZE; Zhang Z; Zhao Y; Yehenala J; Wang S; Zhou G; Hu K; Wu B; Wu CT; Wang S; He Y
Trials; 2020 Jun; 21(1):520. PubMed ID: 32532356
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of Link Natural Sudarshana, an Ayurvedic herbal preparation in COVID-19 patients: A phase II multicenter double-blind randomized placebo-controlled trial.
Wijewickrama A; Idampitiya D; Karunarathne M; Pahalagamage S; Sellahewa K; Govindapala D; Kalambarachchi H; Sooriyarachchi R; Chandrarathne N; Goonaratna C; Perera J
J Ethnopharmacol; 2024 Apr; 323():117535. PubMed ID: 38070837
[TBL] [Abstract][Full Text] [Related]
24. Effect of Jinhua Qinggan granules on novel coronavirus pneumonia in patients.
Liu Z; Li X; Gou C; Li L; Luo X; Zhang C; Zhang Y; Zhang J; Jin A; Li H; Zeng Y; Li T; Wang X
J Tradit Chin Med; 2020 Jun; 40(3):467-472. PubMed ID: 32506862
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness and safety analysis of SanHanHuaShi granules for the treatment of coronavirus disease 2019: Study protocol and statistical analysis plan for a randomized, parallel-controlled, open-label clinical trial.
Liu Y; Chen X; Wang H; Yao C; Gou X; Gao Z; Sun L; Liu D; Tang C; Wei Y; Ding Q; Yang H; Lin J; Chen K; Chen J; Zhao L; Li M; Han L; Wang J; Ren J; Zhang Y
Front Pharmacol; 2022; 13():936925. PubMed ID: 36052134
[No Abstract] [Full Text] [Related]
26. A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive care unit (MelCOVID study): a structured summary of a study protocol for a randomized controlled trial.
Rodríguez-Rubio M; Figueira JC; Acuña-Castroviejo D; Borobia AM; Escames G; de la Oliva P
Trials; 2020 Aug; 21(1):699. PubMed ID: 32758298
[TBL] [Abstract][Full Text] [Related]
27. An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trial.
Alavi Darazam I; Hatami F; Rabiei MM; Pourhoseingholi MA; Moradi O; Shokouhi S; Hajesmaeili MR; Shabani M; Irvani SSN
Trials; 2020 Oct; 21(1):880. PubMed ID: 33106183
[TBL] [Abstract][Full Text] [Related]
28. Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms.
Huang K; Zhang P; Zhang Z; Youn JY; Wang C; Zhang H; Cai H
Pharmacol Ther; 2021 Sep; 225():107843. PubMed ID: 33811957
[TBL] [Abstract][Full Text] [Related]
29. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA
Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849
[TBL] [Abstract][Full Text] [Related]
30. Evaluation on immediate analgesic efficacy and safety of Kai-Hou-Jian spray (children's type) in treating sore throat caused by acute pharyngitis and tonsillitis in children: study protocol for a randomized controlled trial.
Ma YN; Zhong CL; Hu SY; Cai QH; Guo SX
Trials; 2021 Mar; 22(1):216. PubMed ID: 33736674
[TBL] [Abstract][Full Text] [Related]
31. Natural tannin extracts supplementation for COVID-19 patients (TanCOVID): a structured summary of a study protocol for a randomized controlled trial.
Molino S; Pisarevsky A; Mingorance FL; Vega P; Stefanolo JP; Repetti J; Ludueña G; Pepa P; Olmos JI; Fermepin MR; Uehara T; Villapol S; Savidge T; Treangen T; Viciani E; Castagnetti A; Piskorz MM
Trials; 2021 Apr; 22(1):310. PubMed ID: 33910614
[TBL] [Abstract][Full Text] [Related]
32. Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: A structured summary of a study protocol for a multicentre, double-blind randomized controlled trial.
Grau-Pujol B; Camprubí D; Marti-Soler H; Fernández-Pardos M; Guinovart C; Muñoz J
Trials; 2020 Jul; 21(1):688. PubMed ID: 32727613
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
34. Assessing the efficacy and safety of Yinqiao powder-maxing Ganshi decoction in the treatment of the major symptoms of mild and moderate COVID-19 by telemedicine-study protocol for a randomized, double-blind, placebo-controlled trial.
Sum CH; Li TW; Zhang H; Hung HY; Fong BYF; Lin WL; Chow TY; Leung KC; Lo CW; Chia CP; Chan KL; Lin ZX
Front Pharmacol; 2023; 14():1261338. PubMed ID: 38259270
[No Abstract] [Full Text] [Related]
35. Efficacy of Kan Jang
Ratiani L; Pachkoria E; Mamageishvili N; Shengelia R; Hovhannisyan A; Panossian A
Pharmaceuticals (Basel); 2023 Aug; 16(9):. PubMed ID: 37765004
[No Abstract] [Full Text] [Related]
36. Homeopathy for Covid-19 in Primary Care: A structured summary of a study protocol for a randomized controlled trial.
Adler UC; Adler MS; Hotta LM; Padula AEM; de Toledo Cesar A; Diniz JNM; Mestre CAA; Spiller KR; Soares L; de Freitas Santos H; Martinez EZ
Trials; 2021 Feb; 22(1):109. PubMed ID: 33522951
[TBL] [Abstract][Full Text] [Related]
37. Clinical efficacy of Jingyin granules, a Chinese patent medicine, in treating patients infected with coronavirus disease 2019.
Chen B; Yu X; Zhang L; Huang W; Lyu H; Xu Y; Shen J; Yuan W; Fang M; Li M; Gao Y
Phytomedicine; 2023 Jan; 108():154496. PubMed ID: 36288651
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness and safety of Xingbei Zhike granules in patients with postinfectious cough: A multicenter, randomized, double-blinded, placebo-controlled trial.
Chi Y; Lin L; Guo X; Xiao J; Fan F; Yu C; Xue H; Li S; Guo D; Liu L; Wang Y; Ma X; Pang J; Wang J; Zhao Z; Zhao X; Wang G; Gu D; Zhen H; Chen H; Ding J; Zhou M; Wu Z; Han Y; Chen Y; Wu L
Phytomedicine; 2023 Dec; 121():155103. PubMed ID: 37769553
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the efficacy and safety of Melatonin in moderately ill patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Ziaei A; Davoodian P; Dadvand H; Safa O; Hassanipour S; Omidi M; Masjedi M; Mahmoudikia F; Rafiee B; Fathalipour M
Trials; 2020 Oct; 21(1):882. PubMed ID: 33106171
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of Xiangsha Liujun pills on decreased digestive function in convalescent patients of coronavirus disease 2019: a randomized, double blind, placebo controlled clinical trial.
Yuehong Z; Xianzhi S; Qianlong Z; Hualong Z; Jianhua Z; Sisi DU; Jing C; Yingfang L; Haiwang Z; Xinsheng C; Ying H; Fengmei L; Xiaolin T; Yuanming BA
J Tradit Chin Med; 2023 Jun; 43(3):552-558. PubMed ID: 37147757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
